Tag:
RusNano
Latest Headlines
Latest Headlines
Billions in new venture cash targeted at early-stage biotech efforts
The analysts at Burrill & Co. took out their calculators and concluded that $2.6 billion in new venture funds for translation and early-stage work materialized in the U.S. and Europe in the last two months.
Moscow backs clones of Western biotech programs in Russia
Call them Russian biotech clones. With financial support from the Russian government, investors from the country are licensing drugs from Western companies and developing them for Russia.
Domain partners with RusNano on $760M biotech investment plan
RusNano is now partnering with Domain Associates on a $760 million initiative that will invest in about 20 life sciences companies and construct a pharma manufacturing center in Russia to produce next-gen therapies.
Russian fund leads $94.5M investment in two Langer biotechs
A pair of Boston-area biotechs focused on some cutting-edge bionanotechnology inspired by MIT's prolific Bob Langer is splitting a $94.5 million investment windfall spearheaded by RusNano, a
Russian agency backs upstart nano-bio with tailored pricing plan
A Russian state agency is taking a big stake in a newly created U.K. biotech company set up to capitalize on freshly developed nanotech therapies with a plan to adjust the retail prices according to
